Lung Disease News |
AstraZeneca Signs Partnership With Kyowa Hakko Kirin To Commercialize Asthma …
Lung Disease News It will also retain responsibility for furthering the drug's research and development in Japan, and keep hold of rights to participate in some of AstraZeneca's commercial activities. AstraZeneca will be accountable for all sales and marketing in asthma … |
View full post on asthma – Google News